Pavlo Sakhatskyy, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1840 Mease Dr, Suite 307, Safety Harbor, FL 34695 Phone: 727-725-6128 |
Dr. Robert Jay Stein, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1840 Mease Dr, Suite 307, Safety Harbor, FL 34695 Phone: 727-725-6128 Fax: 727-725-6168 |
Stephen Tulane Brown, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1840 Mease Dr, Suite 307, Safety Harbor, FL 34695 Phone: 727-725-6128 |
Kirk A Nelson, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1840 Mease Dr, Suite 307, Safety Harbor, FL 34695 Phone: 727-725-6128 Fax: 727-725-6168 |
Dr. Jack Edward Rashkin, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1840 Mease Dr, Suite 400, Safety Harbor, FL 34695 Phone: 727-725-6128 Fax: 727-725-6168 |
News Archive
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and serious viral infections, today announced financial results for the third quarter of fiscal year (FY) 2010 ended January 31, 2010. The company also provided an update on its clinical programs and corporate developments.
Researchers in the UK say they have isolated bacteria which can grow on and destroy some of the compounds that cause bad breath, and this discovery could help develop a natural way to beat halitosis and other odours such as smelly feet.
Narcotic medications can safely and effectively ease severe, chronic pain in older people with little risk that these patients will seek ever-increasing doses, University of California, San Francisco (UCSF) medical scientists have found. Younger patients, however, are likely to want to rapidly increase their medication dose, the researchers found, posing serious potential health consequences.
Despite recent advances in diagnosis and treatment, the prognosis of patients with biliary tract cancer is still poor. Elucidating the biological characteristics of these carcinomas has become necessary to improve the prognosis of patients and to devise better treatment strategies. A recent study report that invasive front dominant expression of LNγ2 and LNβ3 and active MMP7 play a key role in the progression of biliary tract cancer.
› Verified 7 days ago